High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Dyar, Oliver J ^a   Hoa, Nguyen Q ^b,c   Trung, Nguyen V ^b   Phuc, Ho D ^d   Larsson, Mattias ^a,e   Chuc, Nguyen T K ^b   Lundborg, Cecilia S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

^c Vietnam Cuba Friendship Hospital   (Viet Nam)

^d INSTITUTE OF MATHEMATICS   (Viet Nam)

^e OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; SULFONAMIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; COMMENSAL ESCHERICHIA COLI; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; MALE; NONHUMAN; POPULATION RESEARCH; PRESCHOOL CHILD; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; RURAL AREA; VIET NAM; DRUG EFFECT; DRUG UTILIZATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RURAL POPULATION; STATISTICS;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RURAL POPULATION; VIETNAM;

EID: 84859804689     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-92     Document Type: Article

References (41)

1. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009, 12:476-481. 10.1016/j.mib.2009.08.001, 19716760.
2. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003, 36:1433-1437. 10.1086/375081, 12766839.
3. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
4. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66:1-14. 10.1093/jac/dkq415, 21081548.
5. The European Centre for Disease Prevention and Control The bacterial challenge: Time to react. Stockholm 2009, The European Centre for Disease Prevention and Control.
6. von Baum H, Marre R. Antimicrobial resistance of Escherichia coli and therapeutic implications. Int J Med Microbiol 2005, 295:503-511. 10.1016/j.ijmm.2005.07.002, 16238024.
7. Karami N, Martner A, Enne VI, Swerkersson S, Adlerberth I, Wold AE. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J Antimicrob Chemother 2007, 60:1142-1145. 10.1093/jac/dkm327, 17768176.
8. Blake DP, Hillman K, Fenlon DR, Low JC. Transfer of antibiotic resistance between commensal and pathogenic members of the Enterobacteriaceae under ileal conditions. J Appl Microbiol 2003, 95:428-436. 10.1046/j.1365-2672.2003.01988.x, 12911689.
9. Alekshun MN, Levy SB. Commensals upon us. Biochem Pharmacol 2006, 71:893-900. 10.1016/j.bcp.2005.12.040, 16464437.
10. Isenbarger DW, Hoge CW, Srijan A, Pitarangsi C, Vithayasai N, Bodhidatta L, Hickey KW, Cam PD. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002, 8:175-180. 10.3201/eid0802.010145, 11897070.
11. Duerink DO, Lestari ES, Hadi U, Nagelkerke NJ, Severin JA, Verbrugh HA, Keuter M, Gyssens IC, van den Broek PJ. Study Group Antimicrobial Resistance in Indonesia: Prevalence and Prevention (AMRIN): Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals. J Antimicrob Chemother 2007, 60:377-384. 10.1093/jac/dkm197, 17595290.
12. Ha Nguyen TT, Long Hoang T, Nguyen T. The Tram Nguyen, Lundström G, Olsson-Liljequist B, Kallings I: Antibiotic sensitivity of enteric pathogens in Vietnam. Int J Antimicrob Agents 1991, 1:121-126. 10.1016/0924-8579(91)90006-Y, 18611498.
13. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE. European Antimicrobial Resistance Surveillance System: A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002, 8:278-282. 10.3201/eid0803.010192, 2732471, 11927025.
14. Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O'Brien TF, Pablos-Mendez A, Klugman KP. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005, 5:481-493. 10.1016/S1473-3099(05)70189-4, 16048717.
15. Kalter HD, Gilman RH, Moulton LH, Cullotta AR, Cabrera L, Velapatiño B. Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study. AmJTrop Med Hyg 2010, 82:879-888.
16. Seidman JC, Anitha KP, Kanungo R, Bourgeois AL, Coles CL. Risk factors for antibiotic-resistant E. coli in children in a rural area. Epidemiol Infect 2009, 137:879-888. 10.1017/S0950268808001519, 2841309, 19000341.
17. Sears HJ, Brownlee I, Uchiyama JK. Persistence of individual strains of Escherichia coli in the intestinal tract of man. J Bacteriol 1950, 59:293-301. 385752, 15421958.
18. Osterblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O, Huovinen P, Kotilainen P. A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 2000, 44:1479-1484. 10.1128/AAC.44.6.1479-1484.2000, 89900, 10817696.
19. Hoa NQ, Ohman A, Lundborg CS, Chuc NT. Drug use and health-seeking behavior for childhood illness in Vietnam-a qualitative study. Health Policy 2007, 82:320-329. 10.1016/j.healthpol.2006.10.005, 17118482.
20. Hoa NQ, Larson M, Kim Chuc NT, Eriksson B, Trung NV, Stålsby CL. Antibiotics and paediatric acute respiratory infections in rural Vietnam: health-care providers' knowledge, practical competence and reported practice. Trop Med Int Health 2009, 14:546-555. 10.1111/j.1365-3156.2009.02267.x, 19320870.
21. Hoa NQ, Trung NV, Larsson M, Eriksson B, Phuc HD, Chuc NT, Lundborg CS. Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study. BMC Infect Dis 2010, 10:85. 10.1186/1471-2334-10-85, 2853544, 20356399.
22. Nguyen QH, Nguyen TK, Ho DP, Larsson M, Eriksson B, Lundborg CS. Unnecessary antibiotic use for mild acute respiratory infections during 28-day follow-up of 823 children under five in rural Vietnam. Trans R Soc Trop Med Hyg 2011, 105:628-636. 10.1016/j.trstmh.2011.07.015, 21962293.
23. Chuc NT, Diwan V. FilaBavi, a demographic surveillance site, an epidemiological field laboratory in Vietnam. Scand J Public Health Suppl 2003, 62:3-7.
24. Larsson M, Kronvall G, Chuc NT, Karlsson I, Lager F, Hanh HD, Tomson G, Falkenberg T. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Trop Med Int Health 2000, 5:711-721. 10.1046/j.1365-3156.2000.00630.x, 11044266.
25. WHO WHO collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) classification index with Defined Daily Doses (DDDs) 2009. Oslo 2008, WHO.
26. Hanoi University of Pharmacy VN Pharmacy, the Vietnamese software for Anatomical Therapeutical Chemical Classification System with Defined Daily Dose (ATC/DDD). Hanoi 2004, Hanoi University of Pharmacy.
27. Vilchez S, Reyes D, Paniagua M, Bucardo F, Möllby R, Weintraub A. Prevalence of diarrhoeagenic Escherichia coli in children from León, Nicaragua. J Med Microbiol 2009, 58:630-637. 10.1099/jmm.0.007369-0, 19369525.
28. Nguyen TV, Le Van P, Le Huy C, Gia KN, Weintraub A. Detection and characterization of diarrheagenic Escherichia coli from young children in Hanoi, Vietnam. J Clin Microbiol 2005, 43:755-760. 10.1128/JCM.43.2.755-760.2005, 548099, 15695676.
29. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing 2007, Wayne, PA: Twentieth Informational Supplement M100-S17, Clinical and Laboratory Standards Institute.
30. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing 2010, Wayne, PA: Twentieth Informational Supplement M100-S20, Clinical and Laboratory Standards Institute.
31. European Committee on Antimicrobial Susceptibility Testing European antimicrobial breakpoints. Basel 2011, European Committee on Antimicrobial Susceptibility Testing., http://217.70.33.99/Eucast2/SearchController/search.jsp?action=init
32. Nguyen TV, Le PV, Le CH, Weintraub A. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrob Agents Chemother 2005, 49:816-819. 10.1128/AAC.49.2.816-819.2005, 547323, 15673777.
33. Farra A, Skoog G, Wallén L, Kahlmeter G, Kronvall G, Sörberg M. Swebact Study Group: Antibiotic use and Escherichia coli resistance trends for quinolones and cotrimoxazole in Sweden. Scand J Infect Dis 2002, 34:449-455. 10.1080/00365540110070700, 12160173.
34. Lietzau S, Raum E, von Baum H, Marre R, Brenner H. Household contacts were key factor for children's colonization with resistant Escherichia coli in community setting. J Clin Epidemiol 2007, 60:1149-1155. 10.1016/j.jclinepi.2007.01.016, 17938057.
35. Fornasini M, Reves RR, Murray BE, Morrow AL, Pickering LK. Trimethoprim-resistant Escherichia coli in households of children attending day care centers. J Infect Dis 1992, 166:326-330. 10.1093/infdis/166.2.326, 1634803.
36. de Jong A, Bywater R, Butty P, Deroover E, Godinho K, Klein U, Marion H, Simjee S, Smets K, Thomas V, Vallé M, Wheadon A. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J Antimicrob Chemother 2009, 63:733-744. 10.1093/jac/dkp012, 19233897.
37. European Committee on Antimicrobial Susceptibility Testing Ciprofloxacin/Escherichia coli EUCAST MIC Distribuion. Basel 2011, European Committee on Antimicrobial Susceptibility Testing., http://217.70.33.99/Eucast2/regShow.jsp?Id=1022
38. Kronvall G. Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints. J Clin Microbiol 2010, 48:4445-4452. 10.1128/JCM.01101-10, 3008453, 20926714.
39. Stephan R, Ragettli S, Untermann F. Prevalence and characteristics of verotoxin-producing Escherichia coli (VTEC) in stool samples from asymptomatic human carriers working in the meat processing industry in Switzerland. J Appl Microbiol 2000, 88:335-341. 10.1046/j.1365-2672.2000.00965.x, 10736003.
40. Wilson JB, Clarke RC, Renwick SA, Rahn K, Johnson RP, Karmali MA, Lior H, Alves D, Gyles CL, Sandhu KS, McEwen SA, Spika JS. Vero cytotoxigenic Escherichia coli infection in dairy farm families. J Infect Dis 1996, 174:1021-1027. 10.1093/infdis/174.5.1021, 8896504.
41. Bailey JK, Pinyon JL, Anantham S, Hall RM. Commensal Escherichia coli of healthy humans: a reservoir for antibiotic-resistance determinants. J Med Microbiol 2010, 59:1331-1339. 10.1099/jmm.0.022475-0, 20671087.